Search results
Results from the WOW.Com Content Network
PDL Biopharma (NAS: PDLI) is trading near a 52-week high, and its share price has appreciated more than 30% year to date. This company's revenue comes from licensing its valuable intellectual ...
[2] [3] In 2008 in response to shareholder pressure, PDL spun out its active development programs to a company called Facet Biotech that it capitalized with $400 million. [ 4 ] [ 5 ] Protein Design Labs, founded in 1986 [ 5 ] by cell biologist Laurence J. Korn and mathematician Cary Queen, [ 6 ] was a pioneer in humanizing monoclonal antibodies .
PDL BioPharma (NAS: PDLI) , for example, My guess is that biotech wasn't at the top of the list. However, there are some surprisingly strong dividends in biotech.
With interest rates still sitting near record lows, investors looking for current income have been forced to move from fixed-income positions and into stocks to find yield. To help offset those ...
PDL BioPharma (PDLI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PDLI earnings call for the period ending March 31, 2019.
For premium support please call: 800-290-4726 more ways to reach us
For premium support please call: 800-290-4726 more ways to reach us